| Primary |
| Breast Cancer |
38.2% |
| Breast Cancer Metastatic |
24.1% |
| Hypertension |
8.1% |
| Breast Cancer Female |
5.9% |
| Pain |
5.2% |
| Diabetes Mellitus |
2.7% |
| Metastases To Bone |
2.5% |
| Breast Cancer Stage Iv |
1.5% |
| Osteoporosis |
1.5% |
| Breast Cancer Recurrent |
1.4% |
| Neoplasm Malignant |
1.3% |
| Depression |
1.1% |
| Insomnia |
1.1% |
| Non-small Cell Lung Cancer |
0.9% |
| Anxiety |
0.9% |
| Chest Pain |
0.8% |
| Nausea |
0.8% |
| Hypothyroidism |
0.7% |
| Hypercholesterolaemia |
0.7% |
| Thyroid Disorder |
0.7% |
|
| Pulmonary Embolism |
8.1% |
| Vomiting |
7.5% |
| Death |
7.2% |
| Tumour Marker Increased |
7.2% |
| Nausea |
6.6% |
| Weight Decreased |
5.8% |
| Dyspnoea |
5.5% |
| Disease Progression |
5.2% |
| Injection Site Pain |
5.2% |
| Pain |
4.9% |
| Cerebrovascular Accident |
4.6% |
| Urine Odour Abnormal |
4.6% |
| Neoplasm Progression |
4.3% |
| Pleural Effusion |
4.0% |
| Thrombocytopenia |
3.8% |
| Arthralgia |
3.5% |
| Malignant Neoplasm Progression |
3.2% |
| Alopecia |
2.9% |
| Rash |
2.9% |
| Urinary Tract Infection |
2.9% |
|
| Secondary |
| Breast Cancer |
33.6% |
| Breast Cancer Metastatic |
22.9% |
| Hypertension |
8.3% |
| Product Used For Unknown Indication |
7.7% |
| Pain |
4.5% |
| Diabetes Mellitus |
4.0% |
| Her-2 Positive Breast Cancer |
2.2% |
| Metastases To Bone |
2.1% |
| Invasive Ductal Breast Carcinoma |
2.0% |
| Metastases To Liver |
2.0% |
| Breast Cancer Female |
1.9% |
| Metastases To Lung |
1.6% |
| Glaucoma |
1.2% |
| Neoplasm Malignant |
1.1% |
| Depression |
0.9% |
| Metastases To Bone Marrow |
0.9% |
| Non-small Cell Lung Cancer |
0.8% |
| Breast Cancer Recurrent |
0.8% |
| Hypercholesterolaemia |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
|
| Weight Decreased |
10.6% |
| Renal Failure Acute |
8.4% |
| Metastases To Liver |
7.8% |
| Pulmonary Embolism |
6.7% |
| Neoplasm Progression |
6.1% |
| Optic Neuritis |
5.6% |
| Tumour Marker Increased |
5.6% |
| Anaphylactic Reaction |
5.0% |
| Pain |
5.0% |
| Upper Limb Fracture |
5.0% |
| Malignant Neoplasm Progression |
4.5% |
| Phlebitis |
4.5% |
| Throat Tightness |
3.9% |
| Vomiting |
3.9% |
| Peripheral Sensory Neuropathy |
3.4% |
| Arthralgia |
2.8% |
| Back Pain |
2.8% |
| Cardiac Arrest |
2.8% |
| Dyspnoea |
2.8% |
| Hypertension |
2.8% |
|
| Concomitant |
| Breast Cancer |
26.6% |
| Metastases To Bone |
20.5% |
| Breast Cancer Metastatic |
16.6% |
| Pain |
7.2% |
| Depression |
3.4% |
| Hypertension |
2.9% |
| Osteoporosis |
2.5% |
| Hypercalcaemia |
2.2% |
| Nausea |
2.1% |
| Drug Use For Unknown Indication |
1.9% |
| Prophylaxis |
1.9% |
| Arthritis |
1.8% |
| Product Used For Unknown Indication |
1.6% |
| Diabetes Mellitus |
1.5% |
| Muscle Spasms |
1.5% |
| Insomnia |
1.4% |
| Anaemia |
1.1% |
| Breast Cancer Female |
1.1% |
| Constipation |
1.1% |
| Neoplasm Malignant |
1.0% |
|
| Weight Decreased |
24.7% |
| Tooth Extraction |
8.9% |
| Osteonecrosis |
8.7% |
| Vomiting |
6.3% |
| Osteonecrosis Of Jaw |
5.5% |
| Wound Infection Staphylococcal |
4.3% |
| White Blood Cell Count Increased |
3.9% |
| Toothache |
3.6% |
| Wound Dehiscence |
3.4% |
| Weight Increased |
3.2% |
| White Blood Cell Count Decreased |
3.2% |
| Wound Debridement |
3.2% |
| Tooth Fracture |
3.0% |
| Wheelchair User |
3.0% |
| Tongue Ulceration |
2.8% |
| Wound |
2.8% |
| Urinary Tract Infection |
2.6% |
| Vertebroplasty |
2.6% |
| Walking Aid User |
2.6% |
| Pain In Jaw |
2.2% |
|
| Interacting |
| Lymphomatoid Papulosis |
100.0% |
|
|